Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cell Rep. 2020 Nov 3;33(5):108339. doi: 10.1016/j.celrep.2020.108339.
Here, we report our studies of immune-mediated regulation of Zika virus (ZIKV), herpes simplex virus 1 (HSV-1), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the human cornea. We find that ZIKV can be transmitted via corneal transplantation in mice. However, in human corneal explants, we report that ZIKV does not replicate efficiently and that SARS-CoV-2 does not replicate at all. Additionally, we demonstrate that type III interferon (IFN-λ) and its receptor (IFNλR1) are expressed in the corneal epithelium. Treatment of human corneal explants with IFN-λ, and treatment of mice with IFN-λ eye drops, upregulates antiviral interferon-stimulated genes. In human corneal explants, blockade of IFNλR1 enhances replication of ZIKV and HSV-1 but not SARS-CoV-2. In addition to an antiviral role for IFNλR1 in the cornea, our results suggest that the human cornea does not support SARS-CoV-2 infection despite expression of ACE2, a SARS-CoV-2 receptor, in the human corneal epithelium.
在这里,我们报告了我们在人类角膜中对寨卡病毒(ZIKV)、单纯疱疹病毒 1(HSV-1)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的免疫介导调节的研究。我们发现 ZIKV 可以通过角膜移植在小鼠中传播。然而,在人类角膜外植体中,我们报告说 ZIKV 不能有效复制,SARS-CoV-2 根本不能复制。此外,我们证明 III 型干扰素(IFN-λ)及其受体(IFNλR1)在角膜上皮细胞中表达。用 IFN-λ 处理人角膜外植体,并用 IFN-λ 眼药水处理小鼠,可上调抗病毒干扰素刺激基因。在人角膜外植体中,阻断 IFNλR1 增强了 ZIKV 和 HSV-1 的复制,但不能增强 SARS-CoV-2 的复制。除了 IFNλR1 在角膜中的抗病毒作用外,我们的研究结果表明,尽管人类角膜上皮细胞表达 SARS-CoV-2 受体 ACE2,但人类角膜并不支持 SARS-CoV-2 感染。